# Bernhard Paulweber

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bernhard-paulweber/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,455 |
| Field | Diabetes, Cardiovascular Risks, and Lipoproteins |
| h-index | 64 |
| i10-index | 170 |
| Last Known Institution | Paracelsus Medical University |
| OpenAlex ID | https://openalex.org/A5025058942 |
| ORCID iD | https://orcid.org/0000-0002-1609-4676 |
| Works | 327 |

## Researcher papers

- [3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial](https://scholariq.org/papers/3-years-of-liraglutide-versus-placebo-for-type-2-diabetes-risk-reduction-and/)
- [Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function](https://scholariq.org/papers/genetic-associations-at-53-loci-highlight-cell-types-and-biological-pathways/)
- [The Role of Nutraceuticals in Statin Intolerant Patients](https://scholariq.org/papers/the-role-of-nutraceuticals-in-statin-intolerant-patients/)
- [Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen](https://scholariq.org/papers/genome-wide-association-study-of-diabetic-kidney-disease-highlights-biology/)
- [Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis](https://scholariq.org/papers/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodium/)
- [Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial](https://scholariq.org/papers/anti-interleukin-21-antibody-and-liraglutide-for-the-preservation-of-cell/)

## Researcher topics

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

## Researcher university

- [Paracelsus Medical University](https://scholariq.org/institutions/paracelsus-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.